alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States

              																								United States. Congress. Joint Economic Committee, 1956-					 and 	Eighty-Sixth Congress, 1959-1961.						"Study Paper No. 19 : Debt Management in the United States" in *Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States*			(January 28, 1960).						https://fraser.stlouisfed.org/title/1244/item/3650, accessed on September 26, 2024.	    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
# C_2014212EN.01004501.xml

| 7.7.2014 | EN | Official Journal of the European Union | C 212/45 |
| --- | --- | --- | --- |

7.7.2014

EN

Official Journal of the European Union

C 212/45

---

Action brought on 21 April 2014 — ZZ v Council

(Case F-38/14)

2014/C 212/57

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: S. Rodrigues and C. Bernard-Glanz, lawyers)

Applicant:

Defendant: Council of the European Union

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Civil Service — Action for annulment of the decision of the Secretary-General of the Council to impose the sanction of removal from post with 15 % reduction of invalidity allowance until retirement age

Form of order sought

Form of order sought

| — | Declare the present action admissible; |
| --- | --- |

—

Declare the present action admissible;

| — | Annul the contested decision and, so far as necessary, the decision rejecting the complaint; |
| --- | --- |

—

Annul the contested decision and, so far as necessary, the decision rejecting the complaint;

| — | Order the Council of the European Union to pay the costs. |
| --- | --- |

—

Order the Council of the European Union to pay the costs.

---
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.5140 Anesthesia conduction kit. ( a ) *Identification.* An anesthesia conduction kit is a device used to administer to a patient conduction, regional, or local anesthesia. The device may contain syringes, needles, and drugs.
( b ) *Classification.* Class II (performance standards).
EXHIBIT 32.1
                                  CERTIFICATION

                       Pursuant to 18 U.S.C. Section 1350,
                             As Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

     In connection with this annual report on Form 10-KSB of Volunteer  Bancorp,
Inc.,  I, Reed D. Matney,  Chief  Executive  Officer and  President of Volunteer
Bancorp,  Inc.,  certify,  pursuant to Section 906 of the  Sarbanes-Oxley Act of
2002, that:

     1.   The report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     2.   The  information  contained  in this report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of Volunteer Bancorp.Inc.


Date:  March 29, 2004                      /s/ Reed D. Matney
                                           -------------------------------------
                                           Reed D. Matney
                                           Chief Executive Officer and President
The Honorable William Brevard Hand, United States District Judge for the

1

Southern District of Alabama, sitting by designation.

The Honorable Paul A. Magnuson, Chief Judge, United States District Court for 2

the District of Minnesota.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

_____________

No. 98-1391

_____________

Harvey James Cole, individually and *

as personal representative of *

Margaret Cole, *

*

Appellant, * Appeal from the United States

* District Court for the

v. * District of Minnesota.

*

Upjohn Company, also known as * [UNPUBLISHED]

Pharmacia & Upjohn Company, *

*

Appellee. *

_____________

Submitted: November 19, 1998

Filed: November 27, 1998 

_____________

Before BOWMAN, Chief Judge, LOKEN, Circuit Judge, and HAND, District Judge. 1

_____________

PER CURIAM.

Harvey James Cole appeals the grant of summary judgment by the District

Court in favor of defendant Upjohn Company in this product liability action. Having 2
-2-

considered the appeal, we conclude the District Court did not err in deeming Upjohn's

request for admissions to have been admitted by Cole and in granting summary

judgment.

Accordingly, the judgment of the District Court is affirmed. See 8th Cir. R. 47B.

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the
amended and restated Annual Report of Hemispherx Biopharma, Inc. (the “Company”)
on Form 10-K/A-2 for the fiscal year ended December 31, 2009 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, William A. Carter, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.





/s/ William A. CarterWilliam
      A. Carter, M.D.Chief
      Executive OfficerFebruary
      11, 2011
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                       3,301,649
<SECURITIES>                                60,364,265
<RECEIVABLES>                                6,924,197
<ALLOWANCES>                                         0
<INVENTORY>                                  7,594,106
<CURRENT-ASSETS>                            82,658,154
<PP&E>                                       2,293,702
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              86,738,156
<CURRENT-LIABILITIES>                        5,999,617
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       192,946
<OTHER-SE>                                  80,545,593
<TOTAL-LIABILITY-AND-EQUITY>                86,738,156
<SALES>                                     14,480,981
<TOTAL-REVENUES>                            14,480,981
<CGS>                                        4,469,465
<TOTAL-COSTS>                               11,136,128
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (434,712)
<INCOME-TAX>                                 (450,000)
<INCOME-CONTINUING>                             15,288
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    15,288
<EPS-PRIMARY>                                     0.00
<EPS-DILUTED>                                     0.00
        


</TABLE>
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.160 Ferrous gluconate. ( a ) *Identity.* The color additive ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123, which is incorporated by reference. Copies may be obtained from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( b ) *Specifications.* Ferrous gluconate shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated by reference. The availability of this incorporation by reference is given in paragraph (a) of this section.
( c ) *Uses and restrictions.* Ferrous gluconate may be safely used in amounts consistent with good manufacturing practice for the coloring of ripe olives.
( d ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification requirements of section 721(c) of the act.
[42 FR 15643, Mar. 22, 1977, as amended at 47 FR 946, Jan. 8, 1982; 49 FR 10089, Mar. 19, 1984]
##### 



Exhibit 31.2 CERTIFICATION REQUIRED BY
RULE 13a-14(a) OR RULE 15d-14(d) AND UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Brian R. Schaefgen, certify that:  1.
    
    I have reviewed this Annual Report on Form 10-K of Ambassadors
International, Inc.;  2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;  3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this report;  4.
    
    The registrants other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:  (a)
    
    Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;  (b)
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such
evaluation; and  (c)
    
    Disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and  5.
    
    The registrants other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions):  (a)
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; and  (b)
    
    Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants
internal control over financial reporting. March 12, 2004 /s/ Brian R. Schaefgen  
 56
[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4292]


=======================================================================
-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION


Surrender of License of Small Business Investment Company

    Pursuant to the authority granted to the United States Small 
Business Administration under the Small Business Investment Act of 
1958, under Section 309 of the Act and Section 107.1900 of the Small 
Business Administration Rules and Regulations (13 CFR 107.1900) to 
function as a small business investment company under the Small 
business Investment Company License No. 09/79-0412 issued to Telesoft 
Partners, L.P., and said license is hereby declared null and void.

United States Small Business Administration.

    Dated: January 5, 2010.
Sean J. Green,
AA/Investment.
[FR Doc. 2010-4292 Filed 3-2-10; 8:45 am]
BILLING CODE M
The Honorable Wilson E. Speir Director Opinion No. H-774 Texas Department of Public Safety Re: Whether article 5805 North Lamar Blvd. 6701h, section 5(b), Austin, Texas **78773** V.T.C.S., has altered the confidential nature of accident reports filed by parties to the accident. Dear Colonel Speir: you have requestedour opinion concerning the confidentiality and use of accident reports. Section 47 of article 67016,V.T.C.S.,provides in part:

**All** accidentreports **made** by persons involved in accidents, by garages, or peace officers shall be without prejudice to the individualso reporting and shall be privilegedand for the confidential use **of** the Department or other State agencies having usefor the records for accidentpreventionpurposes. . . . Ssction S(b) **of** article 6701h,V.T.C.S., **as** amended by Acts 1975, 64th Leg., ch. 347,p. 931, provides in part:

Before suspension**of** a license, registration, or privilege, the Departmentmust find that there is a reasonableprobability of a judgmentbeing rendered **against** the person as a result **of** the accident and the amount of security that must be deposited. Por thispurpose itmay consider the report of the investigatingofficer, the accident reports of all parties involved, and any affidavitsof persons having knowledge of the facts.
. . .

p.3271The Honorable Wilson E. Speir - page 2 (H-774)

You have askedwhether article 6701h conflicts with article 67016 and whether accident reportsmay be used by the Department inmaking the determinationprovided in article 6701h. In addition,you ask whether reports would be admissible in an appeal from such a determination, In our view any conflictbetween article 6701d, section 47 and article 6701h, section 5(b), as amended, is limited to the provision on the one hand that reports will be without prejudice and on the other hand that reportsmay be considered by the Department for license suspensionpurposes. In any case, the latterprovision,which permits the use of reports for the Department's internal consideration in license suspension purposes would prevail in regard to reports filed after the effectivedate of the 1974 amendment. However, any **use** must preserve the confidentialityof the reports. Accordingly, in our opinion the Department of Public Safety **may** utilize accident reports inmaking the determination required by article 6701h, section 5(b), so long as the reports remain confidential.
In our view, the requirementof confidentiality found in section 47 of article 6701dwould preclude the admissibility of such accident reports in appeals from the Department's determinationunless the privilege is waived by the

SUMMARY The Department of Public Safety **may** consider accident reports filed by persons involved in accidents in making the determinationof whether there is

pa 3272The Honorable Wilson E. Bpeir - page 3 (~-774)

a reasonableprobabilityof ajudgment being rendered against a person as a result of the accident. The accident reports.wouldnot be admissible in **an** appeal from the Department's determination. Very trulyyours,

APPROVED:

Opinion Committee jwb

p.3273
§ 522.90b Ampicillin trihydrate powder for injection. ( a ) *Specifications.* Each milliliter of aqueous suspension constituted from ampicillin trihydrate powder contains 200, 250, or 400 milligrams (mg) ampicillin equivalents.
( b ) *Sponsors.* See Nos. 000010 and 042791 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.40 of this chapter.
( d ) *Conditions of use* — ( 1 ) *Dogs and cats* — ( i ) *Amount.* 3 mg/pound (lb) of body weight twice daily by subcutaneous or intramuscular injection.
( ii ) *Indications for use.* For treatment of strains of organisms susceptible to ampicillin and associated with respiratory tract infections, urinary tract infections, gastrointestinal infections, skin infections, soft tissue infections, and postsurgical infections.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Cattle* — ( i ) *Amount.* 2 to 5 mg/lb of body weight once daily by intramuscular injection.
( ii ) *Indications for use.* For treatment of respiratory tract infections caused by organisms susceptible to ampicillin, bacterial pneumonia (shipping fever, calf pneumonia, and bovine pneumonia) caused by *Aerobacter* spp., *Klebsiella* spp., *Staphylococcus* spp., *Streptococcus* spp., *Pasteurella multocida,* and *Escherichia coli.*
( iii ) *Limitations.* Do not treat cattle for more than 7 days. Milk from treated cows must not be used for food during treatment and for 48 hours (4 milkings) after the last treatment. Cattle must not be slaughtered for food during treatment and for 144 hours (6 days) after the last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37331, Aug. 18, 1992; 57 FR 42623, Sept. 15, 1992; 58 FR 18304, Apr. 8, 1993; 63 FR 41420, Aug. 4, 1998; 75 FR 10167, Mar. 5, 2010; 76 FR 17338, Mar. 29, 2011; 76 FR 53051, Aug. 25, 2011; 82 FR 21690, May 10, 2017; 85 FR 4208, Jan. 24, 2020]
Exhibit 23.1

CONSENT OF KPMG LLP, INDEPENDENT AUDITORS

The
Board of Directors
LOUD Technologies Inc.:

We
consent to the incorporation by reference in the registration statements (Nos. 33-98720 and 333-107060) on Form S-8 of LOUD
Technologies Inc. of our report dated March 31, 2004, except for the matters discussed in Note 20, as to which the date is April 27, 2004, with respect to the consolidated
balance sheets of LOUD Technologies Inc. as of December 31, 2003 and 2002, and the related consolidated statements of operations, cash flows and shareholders' equity and comprehensive
loss for each of the years in the three-year period ended December 31, 2003, which report appears in the December 31, 2003, annual report on Form 10-K of
LOUD Technologies Inc. Our report refers to a change in the method of accounting for goodwill and other intangible assets as of January 1, 2002.

/s/
KPMG LLP

Seattle,
Washington
May 3, 2004

---
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                              24
<SECURITIES>                                         0
<RECEIVABLES>                                       28
<ALLOWANCES>                                         0
<INVENTORY>                                         58
<CURRENT-ASSETS>                                   112
<PP&E>                                             682
<DEPRECIATION>                                   (453)
<TOTAL-ASSETS>                                     810
<CURRENT-LIABILITIES>                              155
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          2
<COMMON>                                             1
<OTHER-SE>                                         257
<TOTAL-LIABILITY-AND-EQUITY>                       810
<SALES>                                            191
<TOTAL-REVENUES>                                   191
<CGS>                                              112
<TOTAL-COSTS>                                      182
<OTHER-EXPENSES>                                   (5)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  20<F1>
<INCOME-PRETAX>                                    (5)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                (5)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                   (12)
<CHANGES>                                            0
<NET-INCOME>                                      (22)
<EPS-PRIMARY>                                    (.20)
<EPS-DILUTED>                                    (.20)
<FN>
<F1>Net of interest income of $0.8 million.
</FN>
        

</TABLE>
#### Fred C. Roessler et al., Trustees (Estate of Carl Roessler) *v.*New Haven Redevelopment Agency

Although it appears that the trial court ordered a reference in this case without affording either party a hearing as to whether the reference should be to one or three referees under General Statutes § 52-434a and that thereafter it refused to revoke the reference to permit such a hearing, nevertheless, since these rulings were interlocutory ones and no final judgment has been rendered, the defendant’s motion to dismiss (erroneously entitled a motion to erase) the appeal from the Superior Court in New Haven County is granted.

*633
      *Sherman A. Zitomer,*for the appellee (defendant).

*Abraham D. Slavitt*and *Robert G. Zanesky,*for the appellants (plaintiffs).

Argued April 1

decided April 1, 1969